164 related articles for article (PubMed ID: 23377570)
1. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
[TBL] [Abstract][Full Text] [Related]
3. Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus.
Ghadban T; Miro JT; Trump F; Tsui TY; Uzunoglu FG; Reeh M; Gebauer F; Bachmann K; Wellner U; Kalinin V; Pantel K; Izbicki JR; Vashist YK
Clin Genet; 2016 Oct; 90(4):343-50. PubMed ID: 26916598
[TBL] [Abstract][Full Text] [Related]
4. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K
Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer.
Bachmann K; Shahmiri S; Kaifi J; Schurr P; Mann O; Rawnaq T; Block S; Kalinin V; Izbicki JR; Strate T
J Gastrointest Surg; 2009 Feb; 13(2):181-7. PubMed ID: 19052822
[TBL] [Abstract][Full Text] [Related]
6. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.
Lee SJ; Kim KM; Chae MH; Lee WK; Kam S; Cha SI; Han HS; Kim CH; Kang YM; Han SB; Park JY
Cancer Genet Cytogenet; 2007 Jan; 172(1):29-32. PubMed ID: 17175376
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
Lee JM; Yang SY; Yang PW; Shun CT; Wu MT; Hsu CH; Lin CC; Cheng JC; Wang YH; Chuang TH; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Ann Surg Oncol; 2011 Jul; 18(7):2066-73. PubMed ID: 21298351
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
[TBL] [Abstract][Full Text] [Related]
10. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM;
J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891
[TBL] [Abstract][Full Text] [Related]
11. Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.
Vashist YK; Uzungolu G; Kutup A; Gebauer F; Koenig A; Deutsch L; Zehler O; Busch P; Kalinin V; Izbicki JR; Yekebas EF
J Surg Oncol; 2011 Sep; 104(3):305-11. PubMed ID: 21495030
[TBL] [Abstract][Full Text] [Related]
12. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
[TBL] [Abstract][Full Text] [Related]
14. Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
Kharrat N; Al'Fadhli S; Rebaï A
J Recept Signal Transduct Res; 2008; 28(5):475-83. PubMed ID: 18946768
[TBL] [Abstract][Full Text] [Related]
15. An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.
Ghadban T; Schmidt-Yang M; Uzunoglu FG; Perez DR; Tsui TY; El Gammal AT; Erbes PJ; Zilbermints V; Wellner U; Pantel K; Izbicki JR; Vashist YK
J Hum Genet; 2014 Dec; 59(12):661-6. PubMed ID: 25354935
[TBL] [Abstract][Full Text] [Related]
16. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
17. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
Lindner K; Palmes D; Senninger N; Hummel R
Langenbecks Arch Surg; 2015 Feb; 400(2):229-35. PubMed ID: 25572665
[TBL] [Abstract][Full Text] [Related]
18. The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist YK; Kutup A; Musici S; Yekebas EF; Mina S; Uzunoglu G; Zehler O; Koenig A; Cataldegirmen G; Bockhorn M; Effenberger K; Kalinin V; Pantel K; Izbicki JR
Cell Oncol (Dordr); 2011 Aug; 34(4):281-8. PubMed ID: 21340746
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
[TBL] [Abstract][Full Text] [Related]
20. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]